Evaxion A (EVAX) Return on Invested Capital (2021 - 2026)
Evaxion A posted quarterly Return on Invested Capital of 0.01% for Q1 2026, up 3.0% year-on-year from 0.01% in Q1 2025, and up 53.62% on a QoQ basis from 0.03% in Q4 2025.
Evaxion A (EVAX) has 6 years of Return on Invested Capital data on file, last reported at 0.01% in Q1 2026.
- For the quarter ending Q1 2026, Return on Invested Capital rose 3.0% year-over-year to 0.01%; the trailing twelve-month figure through Mar 2026 stood at 0.01% (up 3.0% YoY), and the FY2025 full-year result was 0.01%, up 2.0% from the prior year.
- Return on Invested Capital for Q1 2026 stood at 0.01%, up from 0.03% in the prior quarter.
- Across five years, Return on Invested Capital topped out at 0.01% in Q1 2026 and bottomed at 1.19% in Q3 2023.
- The 5-year median for Return on Invested Capital is 0.11% (2023), against an average of 0.39%.
- The widest annual swing landed in 2023, when Return on Invested Capital plunged 56 bps; it then jumped 51 bps in 2024.
- A 5-year view of Return on Invested Capital shows it stood at 0.03% in 2022, then slumped by 316 bps to 0.11% in 2023, then surged by 58 bps to 0.05% in 2024, then surged by 44 bps to 0.03% in 2025, then jumped by 54 bps to 0.01% in 2026.
- The last three Return on Invested Capital figures came in at 0.01% (Q1 2026), 0.03% (Q4 2025), and 0.44% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -0.01% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.00% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -0.01% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.00% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.01% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | -0.03% |
| Sep 30, 2025 | -0.44% |
| Jun 30, 2025 | -0.59% |
| Mar 31, 2025 | -0.04% |
| Dec 31, 2024 | -0.05% |
| Sep 30, 2024 | -0.68% |
| Jun 30, 2024 | -0.87% |
| Mar 31, 2024 | -0.10% |
| Dec 31, 2023 | -0.11% |
| Sep 30, 2023 | -1.19% |
| Jun 30, 2023 | -0.99% |
| Mar 31, 2023 | -0.03% |
| Dec 31, 2022 | -0.03% |
| Sep 30, 2022 | -0.64% |
| Jun 30, 2022 | -0.75% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.01% |